Officer Transactions Report
2026-09-09SEC Filing 4 (0001193125-26-386790)
This filing details transactions made by Chuang Hao-Yuan, Chief Financial Officer of BELITE BIO, INC, on September 4th and 8th, 2026. A total of 35,135 American depositary shares were sold under a Rule 10b5-1 trading plan. The sales occurred at prices ranging from $180.16 to $198.05. Following these transactions, Mr. Chuang's reported ownership decreased significantly, with the final post-transaction share count at 26,038.